America’s biopharmaceutical research companies currently are developing 180 new medicines to help the nearly 400 million people who have diabetes worldwide. These medicines in development — all either in clinical trials or under review by the FDA — include 30 for type 1 diabetes, 100 for type 2 and 52 …

For both healthy patients and those with metabolic impairment, risk decreased when participants took the recommended daily allowance of magnesium….

Brain activity in region responsible for food anticipation increased while exercising upon exposure to healthy food as opposed to unhealthy alternative….

JDRF announces funding of $7 million to help ensure a rapid transition of ViaCyte’s VC-01 encapsulated cell therapy product into the clinical phase of development….

Prediction algorithms could provide the key….  

Replacing snacks with low-fat yogurt can cut risk nearly in half….

Noninvasive capilaroscopy, laser Doppler flowmetry, and retinal imaging among techniques used….  

Faster way to reprogram fibroblasts to bypass pancreatic-pluripotent state shown in mouse models….  

Self-reported television viewing may not be an accurate measure of total sedentary time….

Possible circumvention for anti-nausea drug, metoclopramide, shows promise….